Log in to save to my catalogue

In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not...

In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d3b08a3b716a42cc9ab670e45e1d74b9

In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response

About this item

Full title

In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response

Publisher

England: BioMed Central Ltd

Journal title

Arthritis research & therapy, 2019-01, Vol.21 (1), p.28-28, Article 28

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Rheumatoid arthritis (RA) is characterized by the presence of autoantibodies like rheumatoid factor (RF), anti-cyclic citrullinated peptide-2 (anti-CCP2), and anti-carbamylated protein (anti-CarP) antibodies. It is currently unclear whether changes in autoantibody levels are associated with disease activity/treatment outcomes and whether they are m...

Alternative Titles

Full title

In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d3b08a3b716a42cc9ab670e45e1d74b9

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d3b08a3b716a42cc9ab670e45e1d74b9

Other Identifiers

ISSN

1478-6362,1478-6354

E-ISSN

1478-6362

DOI

10.1186/s13075-019-1815-0

How to access this item